Dataset Information


White adipose tissue overproduces the lipid-mobilizing factor zinc ?2-glycoprotein in chronic kidney disease.

ABSTRACT: Chronic kidney disease (CKD) is frequently associated with protein-energy wasting, a recognized strong predictive factor of mortality. Zinc ?2-glycoprotein (ZAG) is a new adipokine involved in body weight control through its lipid-mobilizing activity. Here we tested whether the uremic environment in CKD could alter ZAG production by white adipose tissue and contribute to CKD-associated metabolic disturbances. Compared with normal plasma, uremic plasma induced a significant increase in ZAG synthesis (124%), was associated with a significant increase in basal lipolysis (31%), and significantly blunted lipogenesis (-53%) in 3T3-L1 adipocytes in vitro. In 5/6 nephrectomized rats and mice in vivo, there was a significant decrease in white adipose tissue accretion (-44% and -43%, respectively) and a significantly higher white adipose tissue content of ZAG protein than in sham-operated, pair-fed control animals (498% and 106%, respectively). Subcutaneous white adipose tissue biopsies from patients with end-stage renal disease exhibited a higher content of ZAG (573%) than age-matched controls. Thus, the ZAG content is increased in white adipose tissue from patients or animal models with CKD. Overproduction of ZAG in CKD could be a major contributor to metabolic disturbances associated with CKD.

SUBMITTER: Pelletier CC 

PROVIDER: S-EPMC3938447 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC6286258 | BioStudies
2018-01-01 | S-EPMC6266632 | BioStudies
2014-01-01 | S-EPMC4647896 | BioStudies
2019-01-01 | S-EPMC6635360 | BioStudies
2018-01-01 | S-EPMC5808341 | BioStudies
2019-01-01 | S-EPMC6829362 | BioStudies
1000-01-01 | S-EPMC3956172 | BioStudies
2014-01-01 | S-EPMC4113020 | BioStudies
1000-01-01 | S-EPMC5733748 | BioStudies
1000-01-01 | S-EPMC4773761 | BioStudies